Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
776
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $42.9M | 0.01% |
517,208
+351,361
| +212% | +$28M |
2013 Q2
48 quarters
|
|
777
Regal Rexnord
RRX
$10.6B
| $42.9M | 0.01% |
295,785
+66,709
| +29% | +$8.37M |
2013 Q2
48 quarters
|
|
778
WEX
WEX
$5.76B
| $42.8M | 0.01% |
291,069
-339,489
| -54% | -$45.6M |
2013 Q2
48 quarters
|
|
779
PUT
Texas Instruments
TXN
$268B
| $42.2M | 0.01% |
+203,200
| New | +$36.1M |
2025 Q2
0 quarters
|
|
780
Avis
CAR
$3.93B
| $42.2M | 0.01% |
249,492
+198,846
| +393% | +$21.4M |
2013 Q2
48 quarters
|
|
781
Ryman Hospitality Properties
RHP
$8.39B
| $42.2M | 0.01% |
427,342
+92,702
| +28% | +$8.67M |
2013 Q2
48 quarters
|
|
782
Invesco
IVZ
$13.5B
| $42.1M | 0.01% |
2,670,855
-80,852
| -3% | -$1.16M |
2013 Q4
46 quarters
|
|
783
Zillow
Z
$6.16B
| $42.1M | 0.01% |
601,260
+278,561
| +86% | +$18.8M |
2015 Q3
39 quarters
|
|
784
Avantor
AVTR
$10.4B
| $42.1M | 0.01% |
3,125,280
+1,148,655
| +58% | +$15.7M |
2019 Q2
24 quarters
|
|
785
Steris
STE
$20.3B
| $42M | 0.01% |
174,677
-23,277
| -12% | -$5.42M |
2019 Q2
24 quarters
|
|
|
VMRK
786
Vivmark Residential
VMRK
$46.3B
| $41.9M | 0.01% |
620,969
-66,749
| -10% | -$4.59M |
2013 Q2
48 quarters
|
|
787
Texas Pacific Land
TPL
$23.5B
| $41.7M | 0.01% |
118,494
+1,524
| +1% | +$623K |
2022 Q1
13 quarters
|
|
788
Huntington Ingalls Industries
HII
$10.6B
| $41.7M | 0.01% |
172,751
+40,357
| +30% | +$9.01M |
2013 Q2
48 quarters
|
|
789
Match Group
MTCH
$9.26B
| $41.5M | 0.01% |
1,343,375
+239,868
| +22% | +$7.17M |
2022 Q1
13 quarters
|
|
790
Murphy USA
MUSA
$9.47B
| $41.3M | 0.01% |
101,487
+73,042
| +257% | +$33.2M |
2013 Q3
47 quarters
|
|
|
PARA
791
DELISTED
Paramount Global Class B
PARA
| $41.2M | 0.01% |
3,196,980
+385,006
| +14% | +$4.51M |
2022 Q1
13 quarters
|
|
792
AGCO
AGCO
$8.03B
| $41.2M | 0.01% |
399,527
+25,710
| +7% | +$2.45M |
2013 Q2
48 quarters
|
|
793
Sanofi
SNY
$95.7B
| $41M | 0.01% |
848,689
+318,173
| +60% | +$16.3M |
2013 Q2
48 quarters
|
|
794
PUT
Snap
SNAP
$9.44B
| $41M | 0.01% |
4,715,000
+3,970,500
| +533% | +$33M |
2024 Q3
3 quarters
|
|
795
PUT
Boston Scientific
BSX
$61.7B
| $40.8M | 0.01% |
380,000
+206,500
| +119% | +$20.9M |
2024 Q3
3 quarters
|
|
796
Host Hotels & Resorts
HST
$15.5B
| $40.6M | 0.01% |
2,646,156
-286,192
| -10% | -$4.24M |
2013 Q2
48 quarters
|
|
797
PUT
CVS Health
CVS
$111B
| $40.6M | 0.01% |
588,200
+214,700
| +57% | +$14.1M |
2024 Q3
3 quarters
|
|
798
DraftKings
DKNG
$9.23B
| $40.5M | 0.01% |
945,363
-354,561
| -27% | -$12.7M |
2022 Q1
13 quarters
|
|
799
Five Below
FIVE
$12.2B
| $40.5M | 0.01% |
308,481
+257,735
| +508% | +$25.1M |
2013 Q2
48 quarters
|
|
800
CALL
Procter & Gamble
PG
$337B
| $40.5M | 0.01% |
253,900
+30,000
| +13% | +$4.9M |
2023 Q4
6 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.